FDA Issues Long-Planned Draft Guidance On Functional Indications For ICDs
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers who wish to describe the benefits of ICDs in a particular patient population in the device labeling must submit a PMA supplement to FDA with supporting data, according to a 1draft guidance